Obesity Treatment
-
{
- All
- News
- Videos
- Web Stories
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Study Links Advanced Heart And Kidney Disease To Increased Cancer Risk
It is known that high blood sugar, high blood pressure, chronic kidney disease, and obesity, increase the risk of certain cancers. However, the link between cardiovascular-kidney-metabolic stage and the risk of incident cancer wasn't known, the autho
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
Rising Liver Cancer Cases: Are We Ignoring The Warning Signs? Doctor Answers
The rising incidence of liver cancer across the globe is becoming an alarming public health concern. Once considered relatively uncommon in many regions, liver cancer cases are now increasing steadily due to a combination of lifestyle factors, chroni
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
1.3 Billion Globally Have Fatty Liver Disease, Numbers To Reach 2 Billion By 2050: Lancet Study
Driven by obesity and diabetes, the condition is rising rapidly worldwide, often silently increasing risks of cirrhosis and liver cancer.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Can Low Birthweight Predict Stroke Risk? Doctor Breaks Down New Swedish Study
Low birth weight is linked to a higher risk of stroke in early adulthood, affecting both ischemic and hemorrhagic stroke types.
-
PCOS In India: Why Gynaecologists Are Calling It The Biggest Women's Health Concern Today
Polycystic Ovary Syndrome (PCOS) is emerging as a major women's health concern in India due to its rising prevalence, especially among young women.
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
This Is Exactly Why You Must Combat Insulin Resistance Immediately
If the pancreas can no longer manage high blood sugar (hyperglycemia), significant, long-term health issues can arise.
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
How Brown Fat Turns Fuel Into Heat: Study Finds The Protein Behind The Process
The new findings, including how SLIT3 splits into two parts and interacts with receptors to shape nerve and blood vessel networks, point to several potential targets for future treatments.
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Study Links Advanced Heart And Kidney Disease To Increased Cancer Risk
It is known that high blood sugar, high blood pressure, chronic kidney disease, and obesity, increase the risk of certain cancers. However, the link between cardiovascular-kidney-metabolic stage and the risk of incident cancer wasn't known, the autho
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
Rising Liver Cancer Cases: Are We Ignoring The Warning Signs? Doctor Answers
The rising incidence of liver cancer across the globe is becoming an alarming public health concern. Once considered relatively uncommon in many regions, liver cancer cases are now increasing steadily due to a combination of lifestyle factors, chroni
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
1.3 Billion Globally Have Fatty Liver Disease, Numbers To Reach 2 Billion By 2050: Lancet Study
Driven by obesity and diabetes, the condition is rising rapidly worldwide, often silently increasing risks of cirrhosis and liver cancer.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Can Low Birthweight Predict Stroke Risk? Doctor Breaks Down New Swedish Study
Low birth weight is linked to a higher risk of stroke in early adulthood, affecting both ischemic and hemorrhagic stroke types.
-
PCOS In India: Why Gynaecologists Are Calling It The Biggest Women's Health Concern Today
Polycystic Ovary Syndrome (PCOS) is emerging as a major women's health concern in India due to its rising prevalence, especially among young women.
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
This Is Exactly Why You Must Combat Insulin Resistance Immediately
If the pancreas can no longer manage high blood sugar (hyperglycemia), significant, long-term health issues can arise.
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
How Brown Fat Turns Fuel Into Heat: Study Finds The Protein Behind The Process
The new findings, including how SLIT3 splits into two parts and interacts with receptors to shape nerve and blood vessel networks, point to several potential targets for future treatments.
